Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Masnoon Saiyed"'
Autor:
Claire M. Rickard, Emily Larsen, Rachel M. Walker, Gabor Mihala, Joshua Byrnes, Masnoon Saiyed, Marie Cooke, Julie Finucane, Peter J. Carr, Nicole Marsh
Publikováno v:
Journal of Hospital Medicine. 18:21-32
One-third of peripheral intravenous catheters (PIVCs) fail from inflammatory or infectious complications, causing substantial treatment interruption and replacement procedures.We aimed to compare complications between integrated PIVCs (inbuilt extens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::787680825fd23f05f0c57b1ef0fd871e
https://doi.org/10.1002/jhm.12995
https://doi.org/10.1002/jhm.12995
Autor:
Paula Cattanach, Elizabeth Shevill, Gabor Mihala, Nicolette Graham, Masnoon Saiyed, Tricia Kleidon, Jessica A Schults, Amanda J. Ullman, Victoria Gibson, Claire E. Wainwright, Joshua Byrnes, Fiona Macfarlane
Publikováno v:
Pediatric Anesthesia. 31:985-995
BACKGROUND The optimal intravenous device for antibiotic administration for children with respiratory disease is uncertain. We assessed the feasibility of a randomized controlled trial comparing midline catheters with peripherally inserted central ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d4897936ea3c4e9ed1396f9e20881ef
https://doi.org/10.1111/pan.14229
https://doi.org/10.1111/pan.14229
Publikováno v:
Journal of Telemedicine and Telecare. 28:524-529
Introduction Geographical barriers and impaired physical mobility among people with Parkinson’s disease (PD) hinder their timely access to speech pathology services. We compared the costs of delivering a speech treatment via in-person consultation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62515722f1274c04fb2daa9f11c99ee9
https://doi.org/10.1177/1357633x20948302
https://doi.org/10.1177/1357633x20948302
Autor:
Rickard, Claire M., Larsen, Emily, Walker, Rachel M., Mihala, Gabor, Byrnes, Joshua, MPharm, Masnoon Saiyed, Cooke, Marie, MEmerg, Julie Finucane, Carr, Peter J., Marsh, Nicole
Publikováno v:
Journal of Hospital Medicine; Jan2023, Vol. 18 Issue 1, p21-32, 14p
Publikováno v:
International Journal of Pediatrics, Vol 2014 (2014)
Background. In the absence of standard pediatric prescribing information, clinicians often use medicines in an off-label way. Many studies have been published across the globe reporting different rates of off-label use. There is currently no study ba
Externí odkaz:
https://doaj.org/article/0d71e59f092d4b21b9b9e05e0595af50
Autor:
Amanda J. Ullman, Tricia M. Kleidon, Victoria Gibson, Mari Takashima, Jessica Schults, Paula Cattanach, Rebecca Paterson, Marie Cooke, Joshua Byrnes, Masnoon Saiyed, Vineet Chopra, Claire Rickard
Publikováno v:
Pediatric research.
Background Our study aims to explore the experience of having a central venous access device (CVAD) from the perspective of the child and family and how movements within and outside of hospital environments influence this experience. Methods A mixed-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b222c307c4ed308b5db27c89313d08d
https://pubmed.ncbi.nlm.nih.gov/35411069
https://pubmed.ncbi.nlm.nih.gov/35411069
Autor:
Amanda J. Ullman, Victoria Gibson, Mari D. Takashima, Tricia M. Kleidon, Jessica Schults, Masnoon Saiyed, Paula Cattanach, Rebecca Paterson, Marie Cooke, Claire M. Rickard, Joshua Byrnes, Vineet Chopra
Publikováno v:
Pediatric research. 92(5)
Background Healthcare delivery is reliant on a functional central venous access device (CVAD), but the knowledge surrounding the burden of pediatric CVAD-associated harm is limited. Methods A prospective cohort study at a tertiary-referral pediatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a70da1659cc4045f839a81ce02ba6d
https://pubmed.ncbi.nlm.nih.gov/35136199
https://pubmed.ncbi.nlm.nih.gov/35136199
Background and Objective\ud \ud In the REFLECT trial, lenvatinib showed superior clinical benefits to sorafenib in terms of progression-free survival and was non-inferior for overall survival in the treatment of advanced hepatocellular carcinoma (HCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::742e71bc333dcf6dc068d293cf4406e7
Publikováno v:
Journal of Pharmaceutical Health Services Research. 8:91-99
Objectives Prescribing drugs outside regulatory recommendation is known as off-label use. Studies have reported widespread off-label drug use in oncology practice. But the clinical, economic and humanistic outcomes for such practice are often uncerta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17b29c3b5a979bfb3faac70c014989b5
https://doi.org/10.1111/jphs.12175
https://doi.org/10.1111/jphs.12175
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 42:251-258
SummaryWhat is known and objective The off-label use of medicines is widespread in several diseases. This type of prescribing practice is particularly more acute in oncology. However, the suitability of anticancer medications for off-label use remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b24cf082b4b9a42e88f2abd4843552d
https://doi.org/10.1111/jcpt.12507
https://doi.org/10.1111/jcpt.12507